dengu
viru
denv
one
geograph
distribut
pathogen
flavivirus
transmit
mosquito
aed
sp
studi
structureantivir
activ
relationship
glycyrrhiz
acid
gl
deriv
evalu
inhibitori
assay
cytopath
effect
cpe
viral
infect
denv
type
vero
cell
gl
puriti
low
cytotox
vero
cell
inhibit
cpe
reduc
infect
conjug
gl
amino
acid
methyl
ester
introduct
aromat
acylhydrazid
residu
carbohydr
part
strongli
influenc
antivir
activ
among
compound
test
gl
conjug
isoleucin
acid
found
potent
inhibitor
therefor
modif
gl
perspect
way
search
new
antivir
infect
dengu
viru
denv
one
geograph
distribut
pathogen
flavivirus
transmit
mosquito
aed
sp
denv
reemerg
recent
year
pose
threat
health
popul
countri
around
world
consid
one
greatest
viru
threat
mankind
past
year
incid
dengu
fever
increas
result
expans
new
countri
number
case
infect
denv
world
million
peopl
annual
includ
case
dengu
hemorrhag
fever
death
dengu
fever
epidem
seriou
public
health
problem
indonesia
malaysia
myanmar
sri
lanka
thailand
cambodia
philippin
lao
vietnam
india
denv
infect
one
lead
caus
hospit
death
children
due
expand
geograph
expans
denv
mosquito
carri
aed
sp
increas
frequenc
epidem
emerg
dengu
fever
new
area
declar
denv
main
viru
threat
human
accord
antigen
structur
denv
close
yellow
fever
viru
divid
four
serotyp
caus
dengu
fever
dengu
hemorrhag
fever
dengu
shock
syndrom
lead
death
infect
one
serotyp
viru
provid
longterm
resist
serotyp
lead
develop
immun
serotyp
infect
manifest
hemorrhag
fever
character
increas
viremia
vascular
permeabl
character
high
blood
plasma
level
tnf
ifn
vegfa
despit
increas
number
outbreak
dengu
fever
last
decad
current
licens
vaccin
specif
chemotherapi
infect
thu
search
new
antivir
agent
denv
one
urgent
problem
medicin
chemistri
virolog
one
prioriti
area
develop
antivir
drug
use
scaffold
plant
deriv
natur
compound
establish
antivir
activ
new
mechan
antivir
action
chemic
modif
avail
plant
metabolit
screen
antivir
activ
modifi
studi
structureact
relationship
choic
lead
compound
necessari
stage
scientif
basi
creation
new
effect
antivir
agent
treatment
prevent
viral
infect
caus
pathogen
virus
glycyrrhiz
acid
gl
lead
natur
triterpen
glycosid
promis
basi
develop
new
antivir
agent
gl
inhibit
number
dna
rna
virus
vaccinia
new
castl
vesicular
stomat
varicellazost
herp
simplex
type
herp
b
influenza
virus
cytomegalovirus
hepat
b
c
gl
use
clinic
treatment
chronic
viral
hepat
b
c
japan
china
snmc
prepar
compound
glycyrrhizin
ingecpion
inject
compound
glycyrrhizin
ingecpion
tablet
gl
inhibit
reproduct
cultur
cell
suggest
longterm
therapi
hivinfect
patient
combin
antihiv
drug
gl
also
affect
cellular
factor
protein
kinas
ii
casein
kinas
ii
transcript
factor
activ
protein
nuclear
factor
kb
chemic
modif
gl
promis
way
obtain
new
immun
modul
antivir
agent
earli
synthes
seri
amid
amino
acid
dipeptid
conjug
exceed
natur
glycosid
antihiv
activ
gl
deriv
constitut
first
group
substanc
inhibit
marburg
viru
caus
acut
hemorrhag
fever
high
level
lethal
inhibitori
effect
found
gl
deriv
vitro
sarsassoci
coronavirus
among
gl
deriv
inhibitor
epsteinbarr
viru
found
recent
detect
inhibitori
effect
gl
deriv
vitro
influenza
viru
gl
also
interest
scaffold
prepar
potenti
inhibitor
pathogen
flavivirus
like
denv
sinc
report
gl
abil
inhibit
denv
yellow
fever
virus
high
nontox
concentr
antivir
activ
gl
deriv
associ
abil
potenti
product
vitro
vivo
stimul
effect
gl
note
secret
induc
product
interferon
peripher
lymphocyt
antivir
activ
gl
deriv
denv
studi
els
studi
report
firstli
antivir
activ
gl
deriv
fig
conjug
land
damino
acid
methyl
ester
aromat
acylhydrizid
structureantivir
activ
regular
compound
gl
deriv
use
studi
divid
group
group
compound
gl
conjug
contain
three
free
amino
acid
methyl
ester
residu
group
ii
compound
present
gl
conjug
contain
amino
compon
carbohydr
part
glycosid
group
iii
includ
acyl
hydrazid
ester
r
posit
residu
posit
gl
deriv
gl
produc
mono
ammonium
salt
accord
ref
puriti
hplc
trimethyl
ester
produc
gl
use
diazometan
gl
conjug
amino
acid
ester
prepar
use
nhydroxybenzotriazol
hobt
n
dcc
hydrochlorid
dec
describ
previous
gl
conjug
contain
damino
acid
methyl
ester
synthes
accord
ref
conjug
free
amino
acid
accord
ref
compound
contain
residu
aspart
undecano
acid
methyl
ester
carbohydr
part
gl
produc
use
nhydroxysuccinimid
hosu
dcc
analyt
spectral
data
gl
deriv
ident
literatur
data
puriti
compound
monitor
thin
layer
chromatographi
high
pressur
liquid
chromatographi
hplc
puriti
supplementari
materi
supplement
fig
expand
librari
gl
deriv
test
gl
deriv
produc
modif
gl
introduct
aromat
acyl
hydrazid
residu
carbohydr
part
gener
experiment
detail
analyt
spectral
data
ir
c
new
compound
given
supplement
data
bishydrazid
gl
obtain
gl
trimethyl
ester
reflux
hydrazin
hydrat
methanol
yield
ester
methyl
group
aglycon
compound
retain
confirm
presenc
och
shift
ppm
c
nmr
spectrum
aromat
acylhydrazid
produc
reaction
aromat
aldehyd
ethanol
reflux
h
target
compound
isol
column
chromatographi
cc
silica
gel
sg
yield
structur
compound
confirm
ir
c
nmr
spectrum
c
nmr
spectrum
compound
carbon
atom
new
ch
n
bond
detect
ppm
set
signal
aromat
carbon
atom
appear
weak
field
region
ppm
c
nmr
spectrum
bi
hydrazid
contain
shift
carbon
atom
pyridin
residu
weak
field
region
ppm
element
analysi
compound
correspond
calcul
data
see
supplementari
materi
primari
screen
cytotox
antivir
activ
gl
number
deriv
compound
perform
vitro
strain
cytotox
antivir
activ
investig
vero
cell
cultur
support
dulbecco
modifi
medium
dmem
mtt
cytotox
test
compound
perform
vero
cell
cultur
plate
describ
previou
report
cytotox
concentr
calcul
accord
cell
surviv
rate
treat
cell
compar
mock
cell
use
comput
program
john
spoug
ncbi
nih
gl
puriti
use
studi
antivir
activ
refer
sampl
establish
gl
deriv
exceed
tabl
determin
antivir
activ
screen
studi
cytopath
effect
cpe
reduct
initi
conduct
vero
cell
infect
viru
moi
presenc
test
compound
h
incub
infect
cell
photograph
use
revers
phase
contrast
microscopi
microscop
photograph
show
gl
deriv
concentr
significantli
reduc
cpe
cell
infect
gl
low
cytotox
vero
cell
concentrationdepend
inhibit
cpe
posit
cell
inhibit
fig
structur
gl
deriv
compound
tabl
prove
signific
cpe
reduct
infect
cell
repres
greater
inhibit
ratio
cell
infect
cell
treat
indic
deriv
antivir
activ
gl
activ
deriv
reduc
cpe
infect
studi
concentrationdepend
manner
gl
activ
deriv
dosedepend
inhibit
cpe
vero
cell
gl
conjug
isoleucin
compound
show
highest
inhibitori
activ
cpe
concentr
fig
assess
valu
inhibitori
concentr
quantit
analysi
inhibitori
effect
gl
activ
deriv
infect
carri
vitro
immunofluoresc
method
infect
viru
determin
ratio
cell
total
number
cell
stain
dapi
analysi
demonstr
gl
activ
deriv
reduc
number
infect
cell
viral
cell
dosedepend
form
exampl
rate
cell
compound
infect
cell
respect
fig
meanwhil
inhibitori
rate
compound
respect
addit
human
lung
epitheli
cell
use
examin
antivir
activ
gl
deriv
supplement
fig
gl
deriv
exhibit
potent
activ
celltyp
independ
manner
gl
deriv
contain
free
amino
acid
residu
ileoh
tyroh
two
long
chain
amino
acid
fragment
found
highli
activ
valu
significantli
potent
gl
tabl
addit
compound
exhibit
higher
therapeut
index
ti
ti
greater
gl
tyrosin
contain
conjug
less
activ
among
group
gl
deriv
conjug
amino
acid
methyl
ester
r
posit
less
activ
gl
conjug
contain
metom
fragment
show
signific
inhibit
vitro
replic
less
gl
antidenv
activ
conjug
could
link
introduct
metom
r
posit
triterpen
part
smethyl
thioether
side
chain
methionin
might
form
hbond
residu
target
protein
conjug
contain
ileoh
tyroh
r
r
posit
refin
antidenv
activ
conjug
pheoh
drop
antidenv
activ
find
infer
oh
group
tyrosin
play
import
role
donat
accept
hydrogen
bond
residu
viral
target
protein
weak
inhibitori
activ
cpe
test
cell
found
compound
free
triterpen
cooh
group
asp
ome
ome
carbohydr
portion
gl
howev
compound
contain
undecano
acid
methyl
ester
exhibit
potent
efficaci
inhibit
replic
result
indic
undecano
acid
methyl
ester
posit
carbohydr
part
gl
effect
interact
antivir
target
conjug
gl
deriv
group
iii
lost
antivir
activ
weak
inhibit
cell
found
compound
contain
aromat
hydroxyl
group
therefor
structureantivir
activ
studi
indic
gl
conjug
three
free
amino
acid
compound
long
chain
amino
acid
residu
carbohydr
part
compound
exhibit
higher
antidenv
activ
compar
group
iii
deriv
thu
presenc
hydroxyl
group
r
posit
triterpen
part
free
carboxyl
group
amino
acid
import
interact
antivir
target
meanwhil
gl
deriv
compound
significantli
improv
antivir
activ
infect
suggest
isoleucin
tyrosin
undecano
acid
methyl
ester
posit
carbohydr
part
also
interconnect
part
activ
side
antivir
target
conclud
studi
first
report
display
structureantidenv
activ
relationship
gl
deriv
reveal
modif
gl
conjug
amino
acid
introduct
aromat
acyl
hydrazid
residu
carbohydr
part
strongli
influenc
antivir
activ
gl
among
gl
deriv
test
gl
compound
identifi
potent
inhibitor
thu
conjug
gl
deriv
amino
acid
perspect
way
produc
potent
inhibitor
second
way
potenti
gl
activ
modif
introduc
long
chain
amino
acid
carbohydr
part
molecul
keep
triterpen
cooh
group
free
highli
activ
gl
deriv
subject
extens
research
antivir
activ
studi
mechan
antivir
action
use
dock
studi
interact
target
like
proteas
helicas
rnadepend
rna
polymeras
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
fig
inhibit
infect
gl
conjug
isoleucin
compound
vero
cell
infect
moi
analyz
use
immunofluoresc
stain
antibodi
treatment
indic
concentr
compound
infect
discov
ratio
posit
cell
top
total
cell
stain
dapi
